logo







Home>Companies>Jw-therapeutics


Jw therapeutics

Jw therapeutics



JW Therapeutics is a biotechnology company specializing in the development, manufacturing, and commercialization of innovative cell-based immunotherapies for hematological cancers and solid tumors.
Sign up today to get real-time market insights on Jw therapeutics and hundreds of other pre-IPO companies



Jw therapeutics Overview

2016
Biotech
https://www.jwtherapeutics.com



Jw therapeutics Live Market Data

$00000000
$00000000




Jw therapeutics Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO11/3/2020
Series B6/3/2020
Early Stage VC11/20/2019
Series A25/9/2019
Series A15/24/2018




Jw therapeutics Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
ARCH Venture PartnersSeries A2, Series A1, Series BSeries A2 (2019-05-09)
HongShanSeries A2, Series A1, Series BSeries A2 (2019-05-09)
Loyal Valley CapitalSeries A2, Series A1, Series BSeries A2 (2019-05-09)
Temasek HoldingsSeries A2, Series A1, Series BSeries A2 (2019-05-09)
Mirae Asset Global InvestmentsSeries BSeries B (2020-06-03)
Silverhorn Investment AdvisorsSeries BSeries B (2020-06-03)




Jw therapeutics 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Jw therapeutics data




Jw therapeutics Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Jw therapeutics data




Latest Jw therapeutics News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.